Prosecution Insights
Last updated: October 04, 2026

STEMCELL Technologies Canada Inc.

Technology area: Biotechnology & Pharmaceuticals

12 pending office actions • 6 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Analysis

STEMCELL Technologies Canada Inc. manages a portfolio in the Biotechnology & Pharmaceuticals technology area, characterized by 11 pending office actions. These actions are distributed among 11 distinct examiners, indicating a broad engagement with patent office personnel. The portfolio is currently active across 6 distinct art units, which suggests a range of subject matter within the biotechnology sector.

BEHARRY, ZANNA MARIA is the busiest examiner for the company, though this examiner is only responsible for 1 pending office action. This distribution is notable because the 11 pending office actions are spread across 11 examiners, meaning no single examiner holds a majority of the workload. With 11 distinct examiners and 6 distinct art units, the company faces a variety of examination styles and art unit timelines. This level of activity provides a significant amount of data for comparing prosecution experiences across different segments of the Biotechnology & Pharmaceuticals field. The high number of distinct examiners relative to the 11 pending actions indicates a decentralized prosecution environment.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

12
Total Pending OAs
7
Non-Final OAs
4
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (25%)
8
Medium (67%)
1
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (25%)
§112 only1 (8%)
Double-patenting + other5 (42%)
Multi-statute (no §101)3 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
4
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NASHER, AHMED ABDULLALIM-M 1 79.1% +32.5%
BEHARRY, ZANNA MARIA 1 24.7% +56.4%
MARCSISIN, ELLEN JEAN 1 34.5% +49.3%
CANDELARIA, JULIANA IRENE 1 0.0% +0.0%
KASAYAN, KATRIEL BARCELLANO 1 25.0% +0.0%
SCHUBERG, LAURA J 1 23.6% +37.0%
LEITH, NANCY J 1 74.7% +44.1%
VIVLEMORE, TRACY ANN 1 73.0% +6.6%
MATALKAH, FATIMAH KHALAF 1 54.8% +28.6%
KWAK, DEAN P 1 58.7% +37.1%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18569259 COMPOSITIONS AND METHODS FOR BIASING THE POLARITY OF ORGANOIDS KASAYAN, KATRIEL BARCELLANO 6d
18555332 MEDIA AND METHODS FOR GROWING MAMMARY ORGANOIDS SCHUBERG, LAURA J 40d
18726305 MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF BEHARRY, ZANNA MARIA —
18718866 COMPOSITIONS AND METHODS FOR EXPANDING KERATINOCYTES CANDELARIA, JULIANA IRENE —
17562821 MICROFLUIDIC CHIP HAVING INCREASED THROUGHPUT FOR USE IN A SYSTEM FOR DELIVERY OF A PAYLOAD INTO A CELL KWAK, DEAN P —
17425709 ANUCLEATE CELL-DERIVED VACCINES RIGA, MICHAEL ANGELO —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18555332 MEDIA AND METHODS FOR GROWING MAMMARY ORGANOIDS SCHUBERG, LAURA J 40d
19032526 SYSTEMS, METHODS AND APPARATUS FOR THE AUTOMATED CULTURE OF CELLS NASHER, AHMED ABDULLALIM-M —
18726305 MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF BEHARRY, ZANNA MARIA —
18750208 COMPOSITIONS AND METHODS FOR RAPID AND REVERSIBLE BIOMOLECULAR LABELING MARCSISIN, ELLEN JEAN —
18190335 INTRACELLULAR DELIVERY OF BIOMOLECULES TO CELLS COMPRISING A CELL WALL LEITH, NANCY J —
17779830 DEVICES, METHODS AND ASSAYS FOR BIOLOGICAL MATERIALS MATALKAH, FATIMAH KHALAF —
17562821 MICROFLUIDIC CHIP HAVING INCREASED THROUGHPUT FOR USE IN A SYSTEM FOR DELIVERY OF A PAYLOAD INTO A CELL KWAK, DEAN P —

Top Art Units

Art UnitApps
1634 2
1638 2
1631 1
1636 1
1798 1
1644 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19032526 SYSTEMS, METHODS AND APPARATUS FOR THE AUTOMATED CULTURE OF CELLS NASHER, AHMED ABDULLALIM-M — §103DP Non-Final OA — Pending Jan 21, 2025
18726305 MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF BEHARRY, ZANNA MARIA — §102§103§112DP Non-Final OA — Pending Jul 02, 2024
18750208 COMPOSITIONS AND METHODS FOR RAPID AND REVERSIBLE BIOMOLECULAR LABELING MARCSISIN, ELLEN JEAN — §103§112DP Non-Final OA — Pending Jun 21, 2024
18718866 COMPOSITIONS AND METHODS FOR EXPANDING KERATINOCYTES CANDELARIA, JULIANA IRENE — §103§112 Non-Final OA — Pending Jun 12, 2024
18569259 COMPOSITIONS AND METHODS FOR BIASING THE POLARITY OF ORGANOIDS KASAYAN, KATRIEL BARCELLANO 1634 §103 Final Rejection 6d Pending Dec 12, 2023
18555332 MEDIA AND METHODS FOR GROWING MAMMARY ORGANOIDS SCHUBERG, LAURA J 1631 §103 Final Rejection 40d Pending Oct 13, 2023
18190335 INTRACELLULAR DELIVERY OF BIOMOLECULES TO CELLS COMPRISING A CELL WALL LEITH, NANCY J 1636 §112DP Non-Final OA — Pending Mar 27, 2023
17822942 INTRACELLULAR DELIVERY OF COMPLEXES VIVLEMORE, TRACY ANN 1638 §112 Non-Final OA — Pending Aug 29, 2022
17779830 DEVICES, METHODS AND ASSAYS FOR BIOLOGICAL MATERIALS MATALKAH, FATIMAH KHALAF 1638 §103 Final Rejection — Pending May 25, 2022
17562821 MICROFLUIDIC CHIP HAVING INCREASED THROUGHPUT FOR USE IN A SYSTEM FOR DELIVERY OF A PAYLOAD INTO A CELL KWAK, DEAN P 1798 §102§103 Final Rejection — Pending Dec 27, 2021
17425709 ANUCLEATE CELL-DERIVED VACCINES RIGA, MICHAEL ANGELO 1634 §102§103§112Other Non-Final OA — Pending Jul 23, 2021
17282709 INTRACELLULAR DELIVERY OF BIOMOLECULES TO ENHANCE ANTIGEN PRESENTING CELL FUNCTION JUEDES, AMY E 1644 §103§112DP Non-Final OA — Pending Apr 02, 2021

Managing STEMCELL Technologies Canada Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month